Location: New Brunswick, NJ
CIK: 0000200406 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 13, 2026
Total Value: $652M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc. | 2,449,183 | $258M | 39.6% | $105.40 | $42.63 | +147.2% | COM | 74366E102 |
| NBTX | Nanobiotix S.A. | 5,623,816 | $174M | 26.6% | $30.87 | $6.67 | +362.8% | SPONSORED ADS | 63009J107 |
| MGTX | MeiraGTx Holdings plc | 6,641,064 | $57.51M | 8.8% | $8.66 | $9.84 | -12.0% | COM | G59665102 |
| RAPP | Rapport Therapeutics, Inc. | 1,784,517 | $55.84M | 8.6% | $31.29 | $23.15 | +35.2% | COM | 75383L102 |
| CVRX | CVRx, Inc. | 4,024,861 | $38.08M | 5.8% | $9.46 | $19.85 | -52.3% | COM | 126638105 |
| CTNM | Contineum Therapeutics Inc. | 1,979,173 | $25.85M | 4.0% | $13.06 | $16.10 | -18.9% | CL A | 21217B100 |
| LEGN | Legend Biotech Corporation | 814,586 | $14.74M | 2.3% | $18.09 | $41.61 | -56.5% | SPONSORED ADS | 52490G102 |
| XNCR | Xencor, Inc. | 748,062 | $9.022M | 1.4% | $12.06 | $37.91 | -68.2% | COM | 98401F105 |
| PRCT | Procept BioRobotics Corporation | 357,939 | $8.952M | 1.4% | $25.01 | $38.38 | -34.8% | COM | 74276L105 |
| FATE | Fate Therapeutics, Inc. | 3,379,064 | $4.055M | 0.6% | $1.20 | $78.44 | -98.5% | COM | 31189P102 |
| NMRA | Neumora Therapeutics, Inc. | 1,849,445 | $3.606M | 0.6% | $1.95 | $12.57 | -84.5% | COM | 640979100 |
| RLYB | Rallybio Corporation | 152,901 | $1.372M | 0.2% | $8.97 | $6.82 | +31.5% | COM | 75120L209 |
| VOR | Vor Biopharma, Inc. | 53,732 | $959K | 0.1% | $17.84 | $18.62 | -4.2% | COM NEW | 929033207 |
| LAB | Standard BioTools, Inc. | 311,967 | $287K | 0.0% | $0.92 | $2.41 | -61.9% | COM | 34385P108 |
| NNOX | Nano-X Imaging Ltd. | 83,554 | $190K | 0.0% | $2.27 | $15.61 | -85.5% | ORD SHS | M70700105 |
| ACET | Adicet Bio, Inc. | 22,779 | $155K | 0.0% | $6.81 | $11.05 | -38.4% | COM NEW | 007002207 |